$ABBV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbbVie Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AbbVie Inc.. Get notifications about new insider transactions in AbbVie Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2019 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Option Exercise | A | 79.02 | 11,682 | 923,112 | 11,682 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 576 | 0 | 10,354 | 9.8 K to 10.4 K (+5.89 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 1,074 | 0 | 8,869 | 7.8 K to 8.9 K (+13.78 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 874 | 0 | 7,159 | 6.3 K to 7.2 K (+13.91 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Durkin Brian L | VP, Controller | Grant | A | 0.00 | 1,213 | 0 | 5,464 | 4.3 K to 5.5 K (+28.53 %) |
| Jan 04 2019 | ABBV | AbbVie Inc. | Donoghoe Nicholas | SVP, Enterprise Inn ... | Grant | A | 0.00 | 5,565 | 0 | 5,565 | 0 to 5.6 K |
| Jan 03 2019 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 352 | 0 | 21,768 | |
| Jan 03 2019 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 368 | 0 | 14,296 | |
| Jan 03 2019 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 74 | 0 | 6,222 | |
| Jan 02 2019 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Sell | S | 90.00 | 25,000 | 2,250,000 | 134,322 | 159.3 K to 134.3 K (-15.69 %) |
| Dec 28 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Gift | G | 0.00 | 119 | 0 | 159,322 | 159.4 K to 159.3 K (-0.07 %) |
| Dec 28 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Vice Chairman | Gift | G | 0.00 | 1,495 | 0 | 159,441 | 160.9 K to 159.4 K (-0.93 %) |
| Dec 14 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Payment of Exercise | F | 88.60 | 49,852 | 4,416,887 | 160,936 | 210.8 K to 160.9 K (-23.65 %) |
| Dec 14 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Grant | A | 0.00 | 112,530 | 0 | 210,788 | 98.3 K to 210.8 K (+114.53 %) |
| Dec 14 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Sell | S | 90.00 | 60,000 | 5,400,000 | 104,863 | 164.9 K to 104.9 K (-36.39 %) |
| Dec 13 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 88.75 | 16,850 | 1,495,438 | 286,203 | 303.1 K to 286.2 K (-5.56 %) |
| Dec 12 2018 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 11,595 | 0 | 41,073 | 29.5 K to 41.1 K (+39.33 %) |
| Dec 11 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 86.96 | 13,446 | 1,169,264 | 16,904 | 30.4 K to 16.9 K (-44.30 %) |
| Dec 07 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Option Exercise | M | 51.42 | 94,140 | 4,840,679 | 0 | |
| Dec 07 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 91.77 | 9,300 | 853,503 | 98,258 | 107.6 K to 98.3 K (-8.65 %) |
| Dec 07 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 92.37 | 10,000 | 923,705 | 107,558 | 117.6 K to 107.6 K (-8.51 %) |
| Dec 07 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 93.66 | 41,642 | 3,900,385 | 117,558 | 159.2 K to 117.6 K (-26.16 %) |
| Dec 07 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 94.34 | 33,198 | 3,131,959 | 159,200 | 192.4 K to 159.2 K (-17.25 %) |
| Dec 07 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Buy | M | 51.42 | 94,140 | 4,840,679 | 192,398 | 98.3 K to 192.4 K (+95.81 %) |
| Nov 30 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Sell | S | 90.10 | 42,450 | 3,824,940 | 30,350 | 72.8 K to 30.4 K (-58.31 %) |
| Nov 30 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Gift | G | 0.00 | 59 | 0 | 98,258 | 98.3 K to 98.3 K (-0.06 %) |
| Nov 30 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 4,237 | 0 | 303,053 | 307.3 K to 303.1 K (-1.38 %) |
| Oct 02 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 72 | 0 | 6,082 | |
| Oct 02 2018 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 359 | 0 | 13,780 | |
| Oct 02 2018 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 343 | 0 | 21,190 | |
| Aug 21 2018 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Sell | S | 97.91 | 29,200 | 2,859,109 | 82,281 | 111.5 K to 82.3 K (-26.19 %) |
| Aug 21 2018 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Sell | S | 96.97 | 20,800 | 2,016,951 | 111,481 | 132.3 K to 111.5 K (-15.72 %) |
| Jul 02 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 71 | 0 | 5,951 | |
| Jul 02 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 71 | 0 | 5,951 | |
| Jul 02 2018 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 341 | 0 | 20,643 | |
| Jul 02 2018 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 341 | 0 | 20,643 | |
| Jul 02 2018 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 357 | 0 | 13,290 | |
| Jul 02 2018 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 357 | 0 | 13,290 | |
| Jun 29 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Buy | P | 91.90 | 5,400 | 496,274 | 39,735 | 34.3 K to 39.7 K (+15.73 %) |
| Jun 22 2018 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 98.63 | 1,013 | 99,909 | 20,743 | 19.7 K to 20.7 K (+5.13 %) |
| Jun 19 2018 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Buy | S | 99.47 | 17,588 | 1,749,485 | 0 | -17,588 to 0 (-100.00 %) |
| May 07 2018 | ABBV | AbbVie Inc. | Roberts Rebecca B | Director | Grant | A | 0.00 | 1,899 | 0 | 1,899 | 0 to 1.9 K |
| May 07 2018 | ABBV | AbbVie Inc. | WADDELL FREDERICK H | Director | Grant | A | 0.00 | 1,899 | 0 | 17,129 | 15.2 K to 17.1 K (+12.47 %) |
| May 07 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,899 | 0 | 34,335 | 32.4 K to 34.3 K (+5.85 %) |
| May 07 2018 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Grant | A | 0.00 | 1,899 | 0 | 17,629 | 15.7 K to 17.6 K (+12.07 %) |
| May 07 2018 | ABBV | AbbVie Inc. | MEYER MELODY B | Director | Grant | A | 0.00 | 1,899 | 0 | 4,669 | 2.8 K to 4.7 K (+68.56 %) |
| May 07 2018 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Grant | A | 0.00 | 1,899 | 0 | 20,250 | 18.4 K to 20.3 K (+10.35 %) |
| May 07 2018 | ABBV | AbbVie Inc. | Hart Brett J | Director | Grant | A | 0.00 | 1,899 | 0 | 7,643 | 5.7 K to 7.6 K (+33.06 %) |
| May 07 2018 | ABBV | AbbVie Inc. | BURNSIDE WILLIAM H.L. | Director | Grant | A | 0.00 | 1,899 | 0 | 15,129 | 13.2 K to 15.1 K (+14.35 %) |
| May 07 2018 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 1,899 | 0 | 38,195 | 36.3 K to 38.2 K (+5.23 %) |
| May 07 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 1,899 | 0 | 23,688 | 21.8 K to 23.7 K (+8.72 %) |
| May 07 2018 | ABBV | AbbVie Inc. | Roberts Rebecca B | Director | Grant | A | 0.00 | 1,899 | 0 | 1,899 | 0 to 1.9 K |
| May 07 2018 | ABBV | AbbVie Inc. | WADDELL FREDERICK H | Director | Grant | A | 0.00 | 1,899 | 0 | 17,129 | 15.2 K to 17.1 K (+12.47 %) |
| May 07 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,899 | 0 | 34,335 | 32.4 K to 34.3 K (+5.85 %) |
| May 07 2018 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Grant | A | 0.00 | 1,899 | 0 | 17,629 | 15.7 K to 17.6 K (+12.07 %) |
| May 07 2018 | ABBV | AbbVie Inc. | MEYER MELODY B | Director | Grant | A | 0.00 | 1,899 | 0 | 4,669 | 2.8 K to 4.7 K (+68.56 %) |
| May 07 2018 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Grant | A | 0.00 | 1,899 | 0 | 20,250 | 18.4 K to 20.3 K (+10.35 %) |
| May 07 2018 | ABBV | AbbVie Inc. | Hart Brett J | Director | Grant | A | 0.00 | 1,899 | 0 | 7,643 | 5.7 K to 7.6 K (+33.06 %) |
| May 07 2018 | ABBV | AbbVie Inc. | BURNSIDE WILLIAM H.L. | Director | Grant | A | 0.00 | 1,899 | 0 | 15,129 | 13.2 K to 15.1 K (+14.35 %) |
| May 07 2018 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 1,899 | 0 | 38,195 | 36.3 K to 38.2 K (+5.23 %) |
| May 07 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 1,899 | 0 | 23,688 | 21.8 K to 23.7 K (+8.72 %) |
| Apr 13 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 2,115 | 0 | 6,715 | 4.6 K to 6.7 K (+45.98 %) |
| Apr 13 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 5,722 | 0 | 307,290 | 313 K to 307.3 K (-1.83 %) |
| Apr 02 2018 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 330 | 0 | 20,115 | |
| Apr 02 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 69 | 0 | 5,825 | |
| Apr 02 2018 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 346 | 0 | 12,814 | |
| Mar 02 2018 | ABBV | AbbVie Inc. | Michael Robert A. | VP, Controller | Sell | S | 119.44 | 4,294 | 512,853 | 6,876 | 11.2 K to 6.9 K (-38.44 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | Michael Robert A. | VP, Controller | Payment of Exercise | F | 118.26 | 2,387 | 282,287 | 11,170 | 13.6 K to 11.2 K (-17.61 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 117.77 | 1,337 | 157,458 | 93,312 | 94.6 K to 93.3 K (-1.41 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 118.26 | 12,683 | 1,499,892 | 94,649 | 107.3 K to 94.6 K (-11.82 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 118.68 | 18,129 | 2,151,452 | 17,588 | 35.7 K to 17.6 K (-50.76 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 118.26 | 12,183 | 1,440,762 | 35,717 | 47.9 K to 35.7 K (-25.43 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Sell | S | 117.93 | 2,643 | 311,684 | 132,281 | 134.9 K to 132.3 K (-1.96 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Payment of Exercise | F | 118.26 | 27,683 | 3,273,792 | 134,924 | 162.6 K to 134.9 K (-17.02 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 118.26 | 17,418 | 2,059,853 | 72,800 | 90.2 K to 72.8 K (-19.31 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 29.23 | 48,100 | 1,405,795 | 0 | |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 114.43 | 14,829 | 1,696,850 | 97,552 | 112.4 K to 97.6 K (-13.20 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 114.63 | 46,997 | 5,387,463 | 112,381 | 159.4 K to 112.4 K (-29.49 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 113.75 | 19,169 | 2,180,495 | 159,378 | 178.5 K to 159.4 K (-10.74 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 29.23 | 48,100 | 1,405,795 | 178,547 | 130.4 K to 178.5 K (+36.87 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 117.85 | 2,579 | 303,928 | 130,447 | 133 K to 130.4 K (-1.94 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 118.26 | 25,976 | 3,071,922 | 133,026 | 159 K to 133 K (-16.34 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 117.88 | 8,280 | 976,084 | 313,012 | 321.3 K to 313 K (-2.58 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Payment of Exercise | F | 118.26 | 79,491 | 9,400,606 | 321,292 | 400.8 K to 321.3 K (-19.83 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 114.36 | 45,840 | 5,242,262 | 45,840 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 14,991 | 0 | 231,798 | 216.8 K to 231.8 K (+6.91 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 17,319 | 0 | 216,807 | 199.5 K to 216.8 K (+8.68 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 15,945 | 0 | 199,488 | 183.5 K to 199.5 K (+8.69 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | A | 114.36 | 127,610 | 14,593,480 | 127,610 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 39,111 | 0 | 400,783 | 361.7 K to 400.8 K (+10.81 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 45,186 | 0 | 361,672 | 316.5 K to 361.7 K (+14.28 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 42,649 | 0 | 316,486 | 273.8 K to 316.5 K (+15.57 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Michael Robert A. | VP, Controller | Option Exercise | A | 114.36 | 8,030 | 918,311 | 8,030 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | Michael Robert A. | VP, Controller | Grant | A | 0.00 | 1,710 | 0 | 15,387 | 13.7 K to 15.4 K (+12.50 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Michael Robert A. | VP, Controller | Grant | A | 0.00 | 1,975 | 0 | 13,677 | 11.7 K to 13.7 K (+16.88 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Michael Robert A. | VP, Controller | Grant | A | 0.00 | 1,695 | 0 | 11,702 | 10 K to 11.7 K (+16.94 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Option Exercise | A | 114.36 | 46,320 | 5,297,155 | 46,320 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 14,991 | 0 | 162,607 | 147.6 K to 162.6 K (+10.16 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 17,319 | 0 | 147,616 | 130.3 K to 147.6 K (+13.29 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 15,375 | 0 | 130,297 | 114.9 K to 130.3 K (+13.38 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Option Exercise | A | 114.36 | 22,210 | 2,539,936 | 22,210 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Grant | A | 0.00 | 6,840 | 0 | 47,900 | 41.1 K to 47.9 K (+16.66 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Grant | A | 0.00 | 7,902 | 0 | 41,060 | 33.2 K to 41.1 K (+23.83 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Grant | A | 0.00 | 7,080 | 0 | 33,158 | 26.1 K to 33.2 K (+27.15 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 114.36 | 35,440 | 4,052,918 | 35,440 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 11,730 | 0 | 90,218 | 78.5 K to 90.2 K (+14.94 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 13,552 | 0 | 78,488 | 64.9 K to 78.5 K (+20.87 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 14,034 | 0 | 64,936 | 50.9 K to 64.9 K (+27.57 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 114.36 | 44,430 | 5,081,015 | 44,430 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 14,340 | 0 | 159,002 | 144.7 K to 159 K (+9.91 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 16,567 | 0 | 144,662 | 128.1 K to 144.7 K (+12.93 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 13,350 | 0 | 128,950 | 115.6 K to 129 K (+11.55 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Option Exercise | A | 114.36 | 45,840 | 5,242,262 | 45,840 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Grant | A | 0.00 | 14,991 | 0 | 151,152 | 136.2 K to 151.2 K (+11.01 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Grant | A | 0.00 | 17,319 | 0 | 136,161 | 118.8 K to 136.2 K (+14.57 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Grant | A | 0.00 | 13,110 | 0 | 118,842 | 105.7 K to 118.8 K (+12.40 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | A | 114.36 | 23,160 | 2,648,578 | 23,160 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Grant | A | 0.00 | 7,170 | 0 | 107,332 | 100.2 K to 107.3 K (+7.16 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Grant | A | 0.00 | 8,283 | 0 | 100,162 | 91.9 K to 100.2 K (+9.02 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Grant | A | 0.00 | 7,080 | 0 | 91,879 | 84.8 K to 91.9 K (+8.35 %) |
| Jan 03 2018 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 67 | 0 | 5,721 | |
| Jan 03 2018 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 323 | 0 | 19,664 | |
| Jan 03 2018 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 338 | 0 | 12,391 | |
| Jan 03 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 387 | 0 | 29,229 | |
| Dec 19 2017 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Option Exercise | M | 35.88 | 87,040 | 3,122,995 | 0 | |
| Dec 19 2017 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 98.45 | 87,040 | 8,569,053 | 26,078 | 113.1 K to 26.1 K (-76.95 %) |
| Dec 19 2017 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Buy | M | 35.88 | 87,040 | 3,122,995 | 113,118 | 26.1 K to 113.1 K (+333.77 %) |
| Dec 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Option Exercise | M | 35.88 | 1,143 | 41,011 | 0 | |
| Dec 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Option Exercise | M | 35.88 | 144,367 | 5,179,888 | 1,143 | |
| Dec 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Buy | S | 96.86 | 1,143 | 110,711 | 105,732 | 104.6 K to 105.7 K (+1.09 %) |
| Dec 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Buy | M | 35.88 | 1,143 | 41,011 | 106,875 | 105.7 K to 106.9 K (+1.08 %) |
| Dec 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Buy | S | 96.71 | 144,367 | 13,961,271 | 105,732 | -38,635 to 105.7 K (-373.67 %) |
| Dec 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Buy | M | 35.88 | 144,367 | 5,179,888 | 250,099 | 105.7 K to 250.1 K (+136.54 %) |
| Dec 11 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Payment of Exercise | F | 95.95 | 14,235 | 1,365,848 | 50,902 | 65.1 K to 50.9 K (-21.85 %) |
| Nov 24 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 58.88 | 218,193 | 12,847,204 | 109,097 | |
| Nov 24 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 94.01 | 218,193 | 20,511,800 | 273,837 | 492 K to 273.8 K (-44.35 %) |
| Nov 24 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 58.88 | 218,193 | 12,847,204 | 492,030 | 273.8 K to 492 K (+79.68 %) |
| Nov 13 2017 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Sell | S | 94.69 | 25,633 | 2,427,212 | 114,922 | 140.6 K to 114.9 K (-18.24 %) |
| Nov 13 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 2,655 | 0 | 273,837 | 271.2 K to 273.8 K (+0.98 %) |
| Oct 31 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 92.02 | 100 | 9,202 | 65,137 | 65.2 K to 65.1 K (-0.15 %) |
| Oct 31 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 91.22 | 4,482 | 408,849 | 65,237 | 69.7 K to 65.2 K (-6.43 %) |
| Oct 31 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 90.49 | 11,568 | 1,046,814 | 69,719 | 81.3 K to 69.7 K (-14.23 %) |
| Oct 31 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 89.38 | 2,150 | 192,172 | 81,287 | 83.4 K to 81.3 K (-2.58 %) |
| Sep 29 2017 | ABBV | AbbVie Inc. | Michael Robert A. | VP, Controller | Sell | S | 88.00 | 6,699 | 589,512 | 10,007 | 16.7 K to 10 K (-40.10 %) |
| Sep 12 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 24.21 | 4,800 | 116,199 | 0 | |
| Sep 12 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 85.06 | 2,338 | 198,870 | 84,799 | 87.1 K to 84.8 K (-2.68 %) |
| Sep 12 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 85.04 | 1,030 | 87,591 | 87,137 | 88.2 K to 87.1 K (-1.17 %) |
| Sep 12 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 85.03 | 132 | 11,224 | 88,167 | 88.3 K to 88.2 K (-0.15 %) |
| Sep 12 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 85.00 | 3,600 | 305,982 | 88,299 | 91.9 K to 88.3 K (-3.92 %) |
| Sep 12 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 84.99 | 1,200 | 101,988 | 91,899 | 93.1 K to 91.9 K (-1.29 %) |